Morbidity and mortality in the antiphospholipid syndrome

Current Opinion in Pulmonary Medicine

Volumn 15, Issue 5, 2009, Pages 413-417

  Espinosa, Gerard ^a   Cervera, Ricard ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid syndrome; Morbidity; Mortality; Recurrent thrombosis; Treatment

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID DERIVATIVE; IMMUNOGLOBULIN;

ANTIPHOSPHOLIPID SYNDROME; BLEEDING; BRAIN DISEASE; FUNCTIONAL DISEASE; HEART INFARCTION; HUMAN; MORBIDITY; MORTALITY; PLASMAPHERESIS; RECURRENT DISEASE; RECURRENT THROMBOSIS; RELAPSE; REVIEW; STROKE;

ANTIPHOSPHOLIPID SYNDROME; HUMANS; MORBIDITY; SURVIVAL RATE; WORLD HEALTH;

EID: 68949181509     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32832d0463     Document Type: Review

References (18)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
2. Cervera R. Lessons from the 'Euro-Phospholipid' project. Autoimmun Rev 2008; 7:174-178.
3. Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum 2007; 57:1487-1495.
4. Ruiz-Irastorza G, Khamashta MA. The treatment of antiphospholipid syndrome: a harmonic contrast. Best Pract Res Clin Rheumatol 2007; 21:1079-1092.
5. Cervera R, Khamashta MA, Shoenfeld Y, et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1000 patients. Ann Rheum Dis 2008. doi 10.1136/ard.2008.093179.
6. Espinosa G, Bucciarelli S, Asherson RA, et al. Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors. Semin Thromb Haemost 2008; 34:290-294.
7. Bucciarelli S, Cervera R, Espinosa G, et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmun Rev 2006; 6:72-75.
8. Erkan D, Yazici Y, Sobel R, Lockshin MD. Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol 2000; 27:2817-2821.
9. Ames PR, Ciampa A, Margaglione M, et al. Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation: an 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia. Thromb Haemost 2005; 93:694-699.
10. Ruiz-Irastorza G, Khamashta MA, Hunt BJ, et al. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch Intern Med 2002; 162:1164-1169.
11. Bucciarelli S, Erkan D, EspinosaG, Cervera R. Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse. Clin Rev Allerg Immunol 2009; 36:80-84.
12. Espinosa G, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome and sepsis. A common link? J Rheumatol 2007; 34:923-926.
13. Cervera R, Bucciarelli S, Espinosa G, et al. Catastrophic antiphospholipid syndrome: lessons from the 'CAPS Registry' - a tribute to the late Josep Font. Ann NY Acad Sci 2007; 1108:448-456.
14. Erkan D, Asherson RA, Espinosa G, et al. The long-term outcome of catastrophic antiphospholipid syndrome (APS) survivors. Ann Rheum Dis 2003; 62:530-533.
15. Asherson RA, Espinosa G, Menahem S, et al. Relapsing catastrophic antiphospholipid syndrome: report of three cases. Semin Arthritis Rheum 2008; 37:366-372.
16. Willis MS, Bandarenko N. Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease? Semin Thromb Haemost 2005; 31:700-708.
17. Bayraktar UD, Erkan D, Bucciarelli S, et al. The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol 2007; 34:346-352.
18. Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12:530-534.